NBPF3
NBPF family member NBPF3
Also known as: AE2, NBPF3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H094
- Gene
- NBPF3
- Ensembl
- ENSG00000142794
- Chromosome
- 1
- Canonical length
- 633 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear speckles,Cytosol
OverviewNCBI Gene
This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. DUF1220 copy number variations in human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene family contains numerous pseudogenes. [provided by RefSeq, Feb 2013]
Canonical amino-acid sequenceUniProt
633 residues, UniProt reviewed canonical sequence.
>Q9H094|NBPF3
1 MPLTPTVQGF QWTLRGPDVE TSPFGAPRAA SHGVGRHQEL RDPTVPGPTS SATNVSMVVS
61 AGPWSGEKAE MNILEINKKS RPQLAENKQQ FRNLKQKCLV TQVAYFLANR QNNYDYEDCK
121 DLIKSMLRDE RLLTEEKLAE ELGQAEELRQ YKVLVHSQER ELTQLREKLQ EGRDASRSLN
181 QHLQALLTPD EPDNSQGRDL REQLAEGCRL AQHLVQKLSP ENDDDEDEDV KVEEAEKVQE
241 LYAPREVQKA EEKEVPEDSL EECAITCSNS HHPCESNQPY GNTRITFEED QVDSTLIDSS
301 SHDEWLDAVC IIPENESDHE QEEEKGPVSP RNLQESEEEE APQESWDEGD WTLSIPPDMS
361 ASYQSDRSTF HSVEEQQVGL ALDIGRHWCD QVKKEDQEAT SPRLSRELLD EKEPEVLQDS
421 LDRFYSTPFE YLELPDLCQP YRSDFYSLQE QHLGLALDLD RMKKDQEEEE DQGPPCPRLS
481 RELPEVVEPE DLQDSLDRWY STPFSYPELP DSCQPYGSCF YSLEEEHVGF SLDVDEIEKY
541 QEGEEDQKPP CPRLNEVLME AEEPEVLQDS LDRCYSTTST YFQLHASFQQ YRSAFYSFEE
601 QDVSLALDVD NRFFTLTVIR HHLAFQMGVI FPHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NBPF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 9.1 nTPM
Expression across tissuesHPA
Tissue
- testis: 9.1 nTPM
- cerebellum: 2.2 nTPM
- pituitary gland: 1.8 nTPM
- adrenal gland: 1.6 nTPM
- kidney: 1.6 nTPM
- skin: 1.6 nTPM
Single-cell type
- adrenal cortex cells: 99 nCPM
- early primary spermatocytes: 46 nCPM
- leydig cells: 45 nCPM
- oligodendrocyte progenitor cells: 34 nCPM
- late primary spermatocytes: 34 nCPM
- pituitary stem cells: 34 nCPM
Immune cell
- MAIT T-cell: 2.4 nTPM
- gdT-cell: 1.7 nTPM
- naive CD8 T-cell: 1.6 nTPM
- memory CD8 T-cell: 1.4 nTPM
- naive CD4 T-cell: 1.2 nTPM
- eosinophil: 1 nTPM
Brain region
- cerebral cortex: 1 nTPM
- medulla oblongata: 0.9 nTPM
- amygdala: 0.8 nTPM
- cerebellum: 0.8 nTPM
- thalamus: 0.7 nTPM
- basal ganglia: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.03
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NBPF3 as an antibody target. Whether an autoantibody or antibody against NBPF3 could matter depends on whether native NBPF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NBPF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NBPF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...